Cold Laser Therapy in St. Louis

Our console gives four wavelengths. We use several, not one, because of depth and target.

650 nm is in the visible red range. It is soaked up near the surface. We use it for tissue at or near the skin.

808 nm is near-infrared and goes much deeper. That makes it the workhorse for parts below the skin — muscle, tendon, and the tissue around the nerves in your arms and legs.

905 nm is usually given in very short, strong pulses. Pulsing allows high peak power without building up heat. That helps it reach deeper tissue.

980 nm is soaked up more by water and by tissue in general. It adds gentle warmth on top of the light’s chemical effect. That helps local blood flow and relaxes muscle.

A single wavelength is always a compromise. Using several lets us match the treatment to the depth and type of tissue. We do not throw the same light at every problem.

The most widely accepted mechanism runs through cytochrome c oxidase. That is an enzyme in the mitochondria, the power plants of the cell. Red and near-infrared light in this range is soaked up by that enzyme. The result is a more efficient power plant — more usable energy from the same fuel.

Two more effects follow. Nitric oxide had been jamming the enzyme. The light knocks it loose, and that boosts local blood flow. There is also a brief, small rise in reactive oxygen species. This acts as a signal, not as damage. It switches on repair and anti-inflammatory pathways.

This is also why more light is not simply better, the way more of a drug might be. Too little light does nothing. Too much can blunt the response instead of boosting it. That biphasic dose curve is why the settings matter more than raw power. It is also why a clinical device cannot be swapped for a consumer one.

We use photobiomodulation when inflammation, poor healing, or nerve damage in the arms or legs is part of the picture:

• Neuropathic pain, including diabetic neuropathy
• Tendon and soft-tissue injury that has not healed with rest or rehab
• Lasting inflammation around a joint or a nerve
• Helping recovery between procedures
• As one part of wider work on metabolic inflammation, where whole-body inflammation is driving symptoms

When we suspect a nerve problem, we usually prove it first with electrodiagnostic testing. That way treatment is aimed at a confirmed problem, not a guess.

Sessions are short, usually several minutes per area. The handpiece sits right on the skin over the target tissue. Most patients feel nothing at all. At 980 nm some notice mild warmth.

There is no prep and no downtime. You can drive yourself and go right back to work. There are no limits on activity afterward. You wear protective eyewear during treatment.

Photobiomodulation builds up over time. It is not instant. One session rarely makes a lasting change. A course over several weeks is the usual approach. How often and how many depends on what we are treating and how you respond.

We set honest expectations rather than oversell this.

Photobiomodulation does not replace finding the source of your pain. If a nerve root is pinched or a joint is arthritic, light does not change the mechanics. Treating the area without finding the pain source is how patients waste months on therapy that was never going to work.

The evidence is also uneven. It is stronger for some uses — certain soft-tissue and wound-healing uses — than for others. For those others, research is still under way. We will tell you which group your problem falls into.

It is also not the same as a consumer red-light panel. Wavelength, power density and treatment time decide whether anything useful happens at the depth you need. A device built for skin does not reach a part several centimeters down.

Of everything photobiomodulation treats, peripheral neuropathy (nerve damage in the hands and feet) is what we are asked about most. So it is worth being exact about what it can plausibly do and what it cannot.

In diabetic and other metabolic neuropathies, the damage is not only to the nerve fiber. The tiny blood vessels that feed the nerve — the vasa nervorum — are damaged too. The nerve is starved of the blood flow it needs to maintain and repair itself. That tiny-vessel part is where photobiomodulation most likely acts. It boosts local blood flow by releasing nitric oxide. It also improves the power plants in tissue that is starved of energy.

In plain terms, photobiomodulation is aimed at the setting the nerve is trying to survive in. It does not reverse damage that is already done. Fibers that have already died do not come back. But some symptoms come from a starved, inflamed setting around fibers that are still alive. There, the biology gives a fair case for treating it.

It also means the therapy does very little on its own if the metabolic driver is left alone. Steady high blood sugar will keep damaging the nerve faster than any light can help it repair. That is why we treat neuropathy as a metabolic problem and a nerve problem at the same time.

We start by finding what is really causing your symptoms. If we suspect a nerve problem, that usually means electrodiagnostic testing. It confirms whether a nerve is affected, where, and how badly. Treating a guessed neuropathy that turns out to be pain sent down from the low back wastes months.

Next we ask whether inflammation, blood flow or poor healing is a real part of the picture. If it is, photobiomodulation has a sound biological reason and is worth a set trial. If the main problem is mechanical — a pinched nerve root, an arthritic joint, an unstable segment — light will not change the mechanics. We tell you that rather than sell you a course of treatment.

We also set a review point up front. You get a set number of sessions. Then we take an honest look at whether anything measurable has changed. Open-ended treatment with no checkpoint is how patients end up months into something that was never working.